pc:kinas

Kinaset Therapeutics

Kinaset Therapeutics is a clinical-stage biopharmaceutical company developing novel, inhaled therapies for severe respiratory diseases. Its lead program, frevecitinib, is a differentiated inhaled pan-JAK inhibitor designed to deliver broad anti-inflammatory activity directly to the lungs while minimizing systemic exposure.

Leadership & Board

Currently, no data available

Latest Estimated Valuation

Estimated Valuation―

Estimated Valuation―

Total Amount Raised$103M

Total Amount Raised$103M

Total Funding Rounds1

Total Funding Rounds1

Latest Funding Amount$103M

Latest Funding Amount$103M

Latest Funding RoundSeries B

Latest Funding RoundSeries B

Post-Money Valuation―

Post-Money Valuation―

Funding Round

Jan 10, 2026

Series B

$103.00M

―

Investors

Schroders Capital

Series B

RA Capital Management

Series B

Series B

EQT Life Sciences

Series B

Sixty Degree Capital

Series B

Series B

Series B

Willett Advisors

Series B

Related News and Analysis

Steward Partners Deepens Advisor Bench With 29 Forbes Best-In-State Honorees and New Senior Hires

Steward Partners Deepens Advisor Bench With 29 Forbes Best-In-State Honorees and New Senior Hires

New updates have been reported about Steward Partners. Steward Partners is leveraging advisor recognition to reinforce its competitive...

2d ago

Airia Enters Brazil via Strategic Partnership With Performa IT

Airia Enters Brazil via Strategic Partnership With Performa IT

New updates have been reported about Airia. Airia is accelerating its international expansion by forming a strategic partnership...

2d ago

Hadrian Named Representative Vendor as Gartner Recasts Adversarial Exposure Validation Market

Hadrian Named Representative Vendor as Gartner Recasts Adversarial Exposure Validation Market

New updates have been reported about Hadrian. Hadrian has been recognized by Gartner as a Representative Vendor in...

2d ago

Flora Fertility Raises $5M Seed Round to Scale Individually-Owned Fertility Insurance Platform

Flora Fertility Raises $5M Seed Round to Scale Individually-Owned Fertility Insurance Platform

New updates have been reported about Flora Fertility. Flora Fertility has secured a $5 million USD seed round...

2d ago

Vivatides Raises $54 Million Series A to Advance Extrahepatic RNA Therapeutics Platform

Vivatides Raises $54 Million Series A to Advance Extrahepatic RNA Therapeutics Platform

New updates have been reported about Vivatides Therapeutics. Vivatides Therapeutics has closed an oversubscribed $54 million Series A...

2d ago

UpGuard Extends G2 Leadership Streak, Secures Top-100 Global Software Position

UpGuard Extends G2 Leadership Streak, Secures Top-100 Global Software Position

New updates have been reported about UpGuard. UpGuard has strengthened its market position in cybersecurity and third-party risk...

2d ago

Surfin Targets Philippine Digital Finance Growth With SSS Partnership

Surfin Targets Philippine Digital Finance Growth With SSS Partnership

According to a recent LinkedIn post from Surfin, CEO and founder Dr. Yanan Wu discussed how the company...

2d ago

Envision Group Secures $500 Million Vendor Financing Facility With BBVA for Global Renewables

Envision Group Secures $500 Million Vendor Financing Facility With BBVA for Global Renewables

According to a recent LinkedIn post from Envision Group, Envision Energy has entered into a USD 500 million...

2d ago

Genspark Showcases AI Agent Platform and Enterprise-Focused Capabilities

Genspark Showcases AI Agent Platform and Enterprise-Focused Capabilities

A LinkedIn post from Genspark highlights a recent podcast appearance by Co‑Founder and CTO Kay Zhu, focusing on...

2d ago

Industry Recognition Underscores Resolution Therapeutics’ IP Leadership

Industry Recognition Underscores Resolution Therapeutics’ IP Leadership

According to a recent LinkedIn post from Resolution Therapeutics, the company is highlighting recognition for its VP of...

2d ago